Furthermore, the limited availability of advanced imaging modalities, such as PSMA PET scans [13] and multiparametric-MRI [14], in this region may have contributed to the presentation of prostate cancer at more advanced stages. This evidence concerns the gene FOLH1 and prostate carcinoma.